Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Feb;151(2):231-4.
doi: 10.1111/j.1365-2249.2007.03559.x.

Preparing for first-in-man studies: the challenges for translational immunology post-TGN1412

C M Dayan  1 , D C Wraith
Affiliations
Review

Preparing for first-in-man studies: the challenges for translational immunology post-TGN1412

C M Dayan et al. Clin Exp Immunol. 2008 Feb.

Abstract

Current immunology research is generating many new approaches to immunotherapy. However, the recent disaster surrounding the testing of TGN1412, has unsettled regulators and the pharmaceutical industry regarding new immunotherapies and highlighted the complexities of conducting clinical trials with agents that target the immune system. Here we discuss the critical role for immunologists in ensuring that the development of new immunotherapies continues.

PubMed Disclaimer

References

    1. Yousry TA, Major EO, Ryschkewitsch C, et al. Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N Engl J Med. 2006;354:924–33. - PMC - PubMed
    1. Keymeulen B, Vandemeulebroucke E, Ziegler AG, et al. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med. 2005;352:2598–608. - PubMed
    1. Suntharalingam G, Perry MR, Ward S, et al. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med. 2006;355:1018–28. - PubMed
    1. Kenter MJH, Cohen AF. Establishing the risk of human experimentation with drugs: lessons from TGN 1412. Lancet. 2006;368:1387–91. - PubMed
    1. Royal Statistical Society. Report of the working party on statistical issues in first-in-man studies. London: Royal Statistical Society; 2007. - PubMed

MeSH terms